Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies
Public ClinicalTrials.gov record NCT02991898. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Adoptive Transfer of T Regulatory Cell for Suppression of Acute Graft-vs-Host-Disease After an Umbilical Cord Blood Transplant for Hematologic Malignancies
Study identification
- NCT ID
- NCT02991898
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Masonic Cancer Center, University of Minnesota
- Other
- Enrollment
- 3 participants
Conditions and interventions
Conditions
- Acute Lymphoblastic Leukemia
- Acute Myelogenous Leukemia
- Biphenotypic Leukemia
- Burkitt Lymphoma
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Follicular Lymphoma
- Hodgkin Lymphoma
- Large-cell Lymphoma
- Lymphoplasmacytic Lymphoma
- Mantle-Cell Lymphoma
- Marginal Zone B-Cell Lymphoma
- Multiple Myeloma
- Myelodysplastic Syndromes
- Natural Killer Cell Malignancies
- Prolymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Undifferentiated Leukemia
Interventions
- Infusion of Treg Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 15, 2017
- Primary completion
- Jun 19, 2019
- Completion
- Jun 19, 2019
- Last update posted
- Sep 28, 2020
2017 – 2019
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Masonic Cancer Center at University of Minnesota | Minneapolis | Minnesota | 55455 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02991898, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 28, 2020 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02991898 live on ClinicalTrials.gov.